Mark Benvenuto Email & Phone Number

Boston, Ma, Us

Waltham, Massachusetts, United States

Developed and implemented Zenas’ alliance management vision; managed a team of 4 people to refine the Program Management function to enhancing transparency, accountability, and decision making across the portfolio

Waltham, Massachusetts, United States

April-July 2023, Interim head of Clinical Operations

Cambridge, Massachusetts

- Led the Program Management function, instituting a co-leadership model and team structure with associated tools and processes, streamlining operations and accelerating program advancement- Established the Portfolio Review Committee to enable centralized R&D decision making based on robust scientific discourse and data driven decisions, improving corporate operations and efficiency

Cambridge, Ma

Established an internal Alliance Management capability and led initiatives to address operating model challenges to progress a 6-product collaboration with Mylan

Greater Boston Area

- Tasked by the Executive Strategy Council to lead 40 person, $25M business initiative to define and build Cubist’s international infrastructure to support headcount growth and enable global product commercialization; key areas of focus included core financial and HR systems and processes, inventory management, commercial and management reporting, and third party logistics (distribution and order to cash)

- Responsible for optimizing the lifecycle value of Cubicin®, an IV antibiotic with over $1B in worldwide sales, focusing on novel formulations and pediatric exclusivity- Led all aspects of planning and management for the option deal to acquire a privately held pharmaceutical company, expediting the internal decision within 2 weeks of data receipt- Business lead for company-wide initiative to upgrade Oracle enterprise resource planning (ERP) software

- Redesigned and launched the global alliance infrastructure, managing key partnerships and supporting early growth of international business resulting in annual revenues of $50M to Cubist- Responsible for the performance planning and management of Cubist’s international business, developing the tools and metrics to maximize the value of the alliances while building Cubist’s reputation as partner of choice - Led commercial interactions with partner in Japan, resulting in the most… Show more - Redesigned and launched the global alliance infrastructure, managing key partnerships and supporting early growth of international business resulting in annual revenues of $50M to Cubist- Responsible for the performance planning and management of Cubist’s international business, developing the tools and metrics to maximize the value of the alliances while building Cubist’s reputation as partner of choice - Led commercial interactions with partner in Japan, resulting in the most successful launch of Cubicin® outside of the U.S. through the achievement of the launch year revenue goal - Managed Cubist’s commercial alliance with AstraZeneca for the promotion of Merrem®, generating $20M in annual revenue to Cubist Show less

- Managed clinical study teams responsible for the design and execution of phase 1-3 studies, including a 16 country phase 3 clinical trial leading to the FDA approval of Cubicin®- Designed, implemented and managed the Expanded Access Program emergency use protocols, allowing patient access to daptomycin prior to product approval

Managed all Clinical Operations deliverables including training and oversight of site visits from investigator qualification to close-out

Mba, Healthcare Management

Bs, Biology